MedPath

Healthy Diet for Healthy Moms and Babies

Not Applicable
Completed
Conditions
Gestational Diabetes
Obesity
Pregnancy, High Risk
Interventions
Dietary Supplement: Blueberry + soluble fiber
Registration Number
NCT03467503
Lead Sponsor
University of Nevada, Las Vegas
Brief Summary

The purpose of this clinical study is to collect baseline information on dietary habits and metabolic risk factors, and to examine the effects of a dietary intervention focusing on fiber and antioxidant rich berries on the development of gestational diabetes, maternal glucose and lipid control and inflammation in obese pregnant women at risk of developing diabetes. With the ongoing epidemic of obesity, the prevalence of gestational diabetes is significantly increasing and the goal of this research is to identify optimal dietary strategies that can reverse this condition or control the rise in blood glucose among those with already developed diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
34
Inclusion Criteria
  • BMI > or = 30, <20 weeks gestation and singleton pregnancy with the following options: previous history of gestational diabetes and/or family history of diabetes
Exclusion Criteria
  • • Twin or multiple pregnancy

    • Chronic pre-pregnancy conditions (CHD, cancer, diabetes)
    • Gastrointestinal conditions
    • Anemia
    • Allergic to berries and fiber
    • Vegetarian food habits or special diets
    • Not proficient in English and/or unable to provide consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dietary InterventionBlueberry + soluble fiberParticipants were given dietary blueberries (2 cups) and soluble fiber (12g). They also received nutrition educational counseling on healthy dietary habits and gestational weight gain as part of standard prenatal care.
Primary Outcome Measures
NameTimeMethod
Gestational weight gain20 weeks

Maternal weight gain in lbs

Maternal inflammation20 weeks

C-reactive protein as a stable biomarker of inflammation

Gestational glycemia20 weeks

Maternal blood glucose and HbA1c as measures of glycemia

Maternal serum lipids20 weeks

Conventional total, LDL-cholesterol and their particle size to describe lipid profiles

Secondary Outcome Measures
NameTimeMethod
Maternal dietary intakes20 weeks

Maternal intakes of energy intake and nutrients

Maternal biomarkers of atherosclerosis20 weeks

Serum cytokines measured as interleukins and adipokines

Trial Locations

Locations (1)

University of Nevada at Las Vegas

🇺🇸

Las Vegas, Nevada, United States

© Copyright 2025. All Rights Reserved by MedPath